Transforming care for rheumatoid arthritis patients through symptom monitoring

FHS
June 22, 2024
6:17 am

Researchers at The University of Manchester are to trial a system that allows people living with rheumatoid arthritis to send their daily symptoms securely to their health record, in a first for the NHS.

Talkdesk Unveils Talkdesk Autopilot for Healthcare to Modernize Self-Service Experience

What You Should Know: – Talkdesk, a provider of AI-powered contact centers, announced Talkdesk Autopilot for Healthcare at the Healthcare Information and Management Systems Society

March 13, 2024

DF-4101 by AbbVie for Non-Small Cell Lung Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

April 20, 2024

FDA approves Pfizer’s HYMPAVZI to treat haemophilia

The FDA approval of HYMPAVZI was supported by the Phase III BASIS clinical trial. Credit: Andrey_Popov/Shutterstock. Pfizer has announced the approval of HYMPAVZI (marstacimab-hncq) by

October 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.